WAUI
PFE icon

WELLINGTON-ALTUS USA INC.’s Pfizer PFE Stock Holding History

WELLINGTON-ALTUS USA INC.’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.9K Buy
1,742
+150
+9% +$3.92K 0.03% 307
2026
Q1 		$38.3K Buy
1,592
+526
+49% +$14K 0.02% 391
2025
Q4 		$26.5K Buy
+1,066
New +$26.9K 0.02% 429

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WELLINGTON-ALTUS USA INC.'s PFE Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. increased its Pfizer (PFE) stake by 9.4% in Q2 2026, buying an estimated $3.92K and bringing the position to 1,742 shares worth $48.9K. The position accounts for 0.03% of the portfolio, ranked #307.

WELLINGTON-ALTUS USA INC. first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 1,742 shares of Pfizer worth $48.9K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. bought 150 Pfizer shares in Q2 2026, an estimated $3.92K.
  • Pfizer made up 0.03% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #307 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.